Abstract:This narrative review appaises the current pharmacological options for the treatment of obesity, with an emphasis on medications directed at incretin and hormonal receptors. These have experienced increased popularity. Direct and indirect mechanisms of action, efficacy, side effect profiles, and use in clinical practice are discussed. Future directions should optimize patient selection to maximize efficacy and minimize adverse effects. Summary Background Obesity has reached epidemic proportions, with >40% of the US population affected. Although traditionally managed by lifestyle modification, and less frequently by bariatric therapies, there are significant pharmacological advancements. Aims To conduct a narrative review of the neurohormonal and physiological understanding of weight gain and obesity, and the development, clinical testing, indications, expected clinical outcomes, and associated risks of current FDA‐approved and upcoming anti‐obesity medications (AOMs). Methods We conducted a comprehensive review in PubMed for articles on pathophysiology and complications of obesity, including terms 'neurohormonal', 'obesity', 'incretin', and 'weight loss'. Next, we searched for clinical trial data of all FDA‐approved AOMs, including both the generic and trade names of orlistat, phentermine/topiramate, bupropion/naltrexone, liraglutide, and semaglutide. Additional searches were conducted for tirzepatide and retatrutide ‐ medications expecting regulatory approval. Searches included combinations of terms related to mechanism of action, indications, side effects, risks, and future directions. Results We reviewed the pathophysiology of obesity, including specific role of incretins and glucagon. Clinical data supporting the use of various FDA‐approved medications for weight loss are presented, including placebo‐controlled or, when available, head‐to‐head trials. Beneficial metabolic effects, including impact on liver disease, adverse effects and risks of medications are discussed, including altered gastrointestinal motility and risk for periprocedural aspiration. Conclusion AOMs have established efficacy and effectiveness for weight loss even beyond 52 weeks. Further pharmacological options, such as dual and triple incretins, are probable forthcoming additions to clinical practice for combating obesity and its metabolic consequences such as metabolic dysfunction‐associated steatotic liver disease.

Role of Nutraceuticals in Obesity Management: A Mechanism and Prospective Supported by Molecular Docking Studies

Role of Phytomolecules in the Treatment of Obesity: Targets, Mechanisms and Limitations

Phytoactives for Obesity Management: Integrating Nanomedicine for Its Effective Delivery

Targeting Nanotechnology and Nutraceuticals in Obesity: An Updated Approach

The roles of personalized nutrition in obesity and diabetes management: a review

Mobilizing Stockpile of Nature: Phytochemicals, Herbal Extracts, and Dietary Supplements for Managing Metabolic Diseases with Concentric Focus on Obesity

Health Benefits Beyond the Scale: The Role of Diet and Nutrition During Weight Loss Programmes

The Roles of Natural Alkaloids and Polyphenols in Lipid Metabolism: Therapeutic Implications and Potential Targets in Metabolic Diseases

Potential of Gut Microbial Metabolites in Treating Osteoporosis and Obesity: A Network Pharmacology and Bioinformatics Approach

The employment of the nutrigenomic tool in the prevention and reduction of obesity problems: a review

Obesity and aging: Molecular mechanisms and therapeutic approaches

Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities

Exploring the Anti-Obesity Effects of Specific Medicinal Herbs: Focus on Herbal Approaches and their Role in Gut Microbiota

The Role of Gut Microbiota Modulation Strategies in Obesity: The Applications and Mechanisms

The Multifunctional Role of Herbal Products in the Management of Diabetes and Obesity: A Comprehensive Review

Pharmacologic management of obesity: Updates on approved medications, indications and risks

Advances in Anti-obesity Pharmacotherapy: Current Treatments, Emerging Therapies, and Challenges

Precision Nutrition Unveiled: Gene–Nutrient Interactions, Microbiota Dynamics, and Lifestyle Factors in Obesity Management

The Potential Effects of Dietary Antioxidants in Obesity: A Comprehensive Review of the Literature

The metabolic effect of medicinal plants and synthetic anti-obesity products on human health

Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment